You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LY2835219

Showing 1 - 25 of 74
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sarcoma, Dedifferentiated Liposarcoma Trial in New York (Abemaciclib)

Active, not recruiting
  • Sarcoma
  • Dedifferentiated Liposarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 17, 2022

Tumors, Child, Adolescent Trial in Leiden (Ramucirumab, Cyclophosphamide, Vinorelbine)

Recruiting
  • Neoplasms
  • +2 more
  • Leiden, Netherlands
    Leids Universitair Medisch Centrum
Aug 14, 2023

Retroperitoneal Sarcoma Trial in Seattle (drug, procedure, radiation)

Not yet recruiting
  • Retroperitoneal Sarcoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 5, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in Duarte

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Nov 1, 2022

Breast Cancer Trial (Giredestrant, Abemaciclib, Inavolisib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Feb 1, 2023

Metastatic Malignant Solid Tumor, Metastatic NUT Carcinoma, Unresectable Malignant Solid Tumor Trial (Abemaciclib, BET

Suspended
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • Boston, Massachusetts
    Dana-Farber - Harvard Cancer Center LAO
Sep 17, 2022

Breast Cancer Trial in Boston (Abemaciclib)

Terminated
Has Results
  • Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Oct 3, 2022

Cancer, Cancer Metastatic, BRAF V600E Trial in Indianapolis (Abemaciclib, LY3214996)

Recruiting
  • Cancer
  • +6 more
  • Indianapolis, Indiana
    Indiana University Hospital / IU Simon Cancer Center
Jan 12, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Thyroid Cancer, Anaplastic Thyroid Cancer, Undifferentiated Thyroid Cancer Trial in Stanford (Abemaciclib)

Active, not recruiting
  • Thyroid Cancer
  • +2 more
  • Stanford, California
    Stanford University
Nov 8, 2022

Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma Trial in United States

Suspended
  • Recurrent Ovarian High Grade Serous Adenocarcinoma
  • Recurrent Platinum-Resistant Ovarian Carcinoma
  • Phoenix, Arizona
  • +8 more
Jul 26, 2022

Advanced Cancer Trial in Kashiwa, Yokohama (Abemaciclib, Abiraterone Acetate, Prednisolone)

Completed
  • Advanced Cancer
  • Kashiwa, Chiba, Japan
  • +1 more
Sep 20, 2021

Glioblastoma Trial in United States (Abemaciclib, Surgery)

Active, not recruiting
  • Glioblastoma
  • Los Angeles, California
  • +6 more
Dec 28, 2022

Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in Los Angeles

Recruiting
  • Recurrent Endometrial Carcinoma
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 28, 2021

Anatomic Stage IV Breast Cancer AJCC v8, HER2 Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Yuma, Arizona
  • +5 more
May 25, 2022

Non Small Cell Lung Cancer, Breast Cancer Trial in Worldwide (Abemaciclib, Pembrolizumab, Anastrozole)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Breast Cancer
  • Fayetteville, Arkansas
  • +22 more
Aug 8, 2022

Advanced Cancer Trial in Santa Monica, Boston, San Antonio (LY2835219, Fulvestrant)

Active, not recruiting
  • Advanced Cancer
  • Santa Monica, California
  • +2 more
Oct 4, 2021

Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma, Metastatic Malignant

Withdrawn
  • Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
  • +3 more
  • (no location specified)
Oct 13, 2021

Advanced Dedifferentiated Liposarcoma Trial in United States (Abemaciclib, Placebo)

Recruiting
  • Advanced Dedifferentiated Liposarcoma
  • Jacksonville, Florida
  • +6 more
Jul 27, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Birmingham, Alabama
  • +12 more
Nov 9, 2022

Endometrial Endometrioid Adenocarcinoma Trial in Chicago (Abemaciclib, Letrozole, Therapeutic Conventional Surgery)

Recruiting
  • Endometrial Endometrioid Adenocarcinoma
  • Chicago, Illinois
  • +1 more
Apr 30, 2021

Prostatic Tumors Trial in Germany, Spain, United States (Abemaciclib, Darolutamide, LHRH agonist/antagonist)

Not yet recruiting
  • Prostatic Neoplasms
  • Mineola, New York
  • +14 more
Aug 23, 2023

Sarcoma, Ewing, Tumor Metastasis Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)

Not yet recruiting
  • Sarcoma, Ewing
  • Neoplasm Metastasis
  • Phoenix, Arizona
  • +29 more
Aug 17, 2022

Relapsed Solid Tumor, Refractory Solid Tumor Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)

Recruiting
  • Relapsed Solid Tumor
  • Refractory Solid Tumor
  • Phoenix, Arizona
  • +28 more
Dec 7, 2022

Brain Tumor Trial in United States (abemaciclib)

Active, not recruiting
  • Brain Tumor
  • Hartford, Connecticut
  • +7 more
Mar 30, 2022